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1. Introduction 
Numerous studies have reported that high dietary fructose 
intake is associated with various adverse metabolic 
disturbances in different animal models, including obesity, 
hypertriglyceridemia, and insulin resistance (Rutledge 
and Adeli, 2007; Dekker et al., 2010; Collison et al., 2011; 
Newell-Fugate et al., 2014), which successfully mimic 
nutrition-related disorders in the human population. 
However, over the last decade a series of questions have 
arisen regarding the role of fructose in the development 
of the current epidemic of metabolic disorders (Tappy 
and Mittendorfer, 2012). In addition, the mechanism 
underlying the hyperlipidemic effects of fructose remains 
controversial, since it appears that only a small percentage 
of the ingested fructose in the human diet (<1%) is 
directly converted to plasma triglycerides (Sun and 
Empie, 2012). Whether fructose overconsumption will 
lead to hypertriglyceridemia and hepatic steatosis depends 
primarily on the balance between de novo lipogenesis 
and fatty acid oxidation (Rebollo et al., 2014b). Rodent 
models provide the most convenient way to investigate 
the underlying molecular mechanism and to test potential 
therapeutic interventions in the human population 
(Panchal and Brown, 2011).
One of the master transcriptional regulators of fatty 
acid oxidation is peroxisome proliferator-activated 
receptor α (PPARα), which acts as a cellular fatty acid 
sensor (Moreno et al., 2010). Upon activation, PPARα 
induces the expression of multiple genes encoding 
proteins involved in the mitochondrial β-oxidation of fatty 
acids (Minnich et al., 2001). The transcriptional activation 
of target genes by PPARα requires the recruitment of 
peroxisome proliferator-activated receptor γ coactivator 
1α (PGC-1α) (Vega et al., 2000) and lipin-1, which acts 
as an amplifier of the PPARα/PGC-1α signaling system 
(Finck et al., 2006). The nuclear PPARα/PGC-1α/lipin-1 
complex stimulates the expression of genes involved in fatty 
acid oxidation, including carnitine palmitoyltransferase 
1 (CPT1) and medium chain acyl-CoA dehydrogenase 
(Leone et al., 1999). CPT1 represents a rate-limiting 
enzyme for β-oxidation, a process that begins with the 
transport of free fatty acids delivered from circulation 
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into the mitochondria by a CPT1/CPT2 shuttle system 
(Bonnefont et al., 2004). Interestingly, CPT1 activity is 
inhibited by malonyl-CoA, which is the product of the 
enzyme acetyl-CoA carboxylase (ACC) that catalyzes 
the first reaction of de novo lipogenesis. Therefore, 
reciprocal regulatory mechanisms have a crucial role in 
maintaining a balance between the opposite processes of 
lipid metabolism.
De novo lipogenesis in the liver is controlled by several 
transcription factors, including sterol regulatory element 
binding proteins (SREBPs) (Horton et al., 2002). SREBP-1c 
regulates triglyceride synthesis through the expression of 
several downstream target genes, such as ACC, fatty acid 
synthase (FAS), and stearoyl-CoA desaturase 1 (SCD1) 
(Horton et al., 2002). Subsequent studies implied that 
fructose-induced triglyceride accumulation is a result of 
de novo lipogenesis and that it is not driven by dietary lipid 
uptake (Nunes et al., 2014). However, the development of 
hepatic steatosis and hypertriglyceridemia depends not 
only on lipogenesis but also on the fatty acid oxidation in 
the liver. The importance of these processes in fructose-
induced metabolic disturbances is still unclear; therefore, 
the aim of this study was to examine the effect of a high 
fructose diet (60% fructose solution) on both β-oxidation 
and de novo lipogenesis in the livers of male Wistar rats. 
Towards that end, we investigated hepatic lipid metabolism 
by examining the expression of key proteins of fatty acid 
β-oxidation (PPARα, PGC-1, nuclear lipin-1, CPT1) and 
de novo lipogenesis (SREBP-1c, ACC, FAS). The blood 
levels of free fatty acids (FFAs), triglycerides, and glucose, 
as well as liver triglyceride levels, were also compared 
between fructose-fed rats and animals on a control diet.
2. Materials and methods
2.1. Animals and diet
Male Wistar rats aged 21 days, bred in our laboratory, 
were randomly divided into two experimental groups 
(n = 9 animals per group) according to diet regime for 9 
weeks. The control group had standard laboratory chow 
(Veterinary Institute, Subotica, Serbia) and drinking water 
available ad libitum, while the fructose-fed group was 
given the same food with both a 60% fructose (API-Pek, 
Becej, Serbia) solution and drinking water ad libitum. The 
detailed composition of the diet was published previously 
(Velickovic et al., 2013). Drinking water was provided 
for the fructose-fed group in order to avoid possible 
disturbances of the rats’ electrolyte–water balance. The 
animals were kept in a temperature-controlled room (22 
± 2 °C) with a 12 h light/dark cycle (lights on at 0700 
hours) and constant humidity. Daily food and fluid intake 
were measured throughout the treatment. Total energy 
intake was expressed as kJ per animal per day and was 
calculated as previously reported (Vasiljevic et al., 2014). 
The protocols were in compliance with Directive 2010/63/
EU on the protection of animals used for experimental 
and other scientific purposes and were approved by the 
Ethics Committee for the Use of Laboratory Animals of 
the Institute for Biological Research “Siniša Stanković”, 
University of Belgrade (reference number 3-12/12). 
2.2. Blood plasma preparation, tissue collection, and 
determination of biochemical parameters 
After overnight fasting, the animals were sacrificed by 
decapitation with a guillotine (Harvard-Apparatus, USA), 
always at the same time (0900–1000 hours). Trunk blood 
was rapidly collected into EDTA-containing tubes and the 
glucose and triglyceride concentrations were measured 
using a MultiCare apparatus with MultiCare glucose strips 
(product code 23955) and MultiCare triglyceride strips 
(product code 23960) (Biochemical Systems International, 
Italy). Blood plasma was isolated by centrifugation at 
1600 × g for 10 min at room temperature and stored at 
–70 °C. Livers, perfused with cold 0.9% NaCl, and visceral 
adipose tissue (retroperitoneal and omental depots) were 
both carefully excised and kept in liquid nitrogen for 
later RNA and protein isolation. Liver triglycerides were 
isolated from 100 mg of liver tissue using a modified Folch 
method (Folch et al., 1957) and analyzed with the modified 
colorimetric method of Fletcher (Fletcher, 1968). FFA 
plasma level was determined by using a modified version 
of Duncombe’s (1964) method.
2.3. Preparation of cytoplasmic, nuclear, and whole-cell 
extracts of the liver
Frozen livers from individual animals were weighed 
and homogenized with a Janke–Kunkel Ultra-Turrax 
in 4 volumes (w/v) of ice-cold homogenization buffer 
(20 mM Tris-HCl, pH 7.2, 10% glycerol, 50 mM NaCl, 
1 mM EDTA-Na2, 1 mM EGTA-Na2, 2 mM DTT, and 
protease and phosphatase inhibitors). The homogenates 
were further processed to obtain cytoplasmic and nuclear 
fractions, as described previously (Vasiljevic et al., 2013). 
All steps were conducted at 4 °C and all samples were 
divided into aliquots and stored at –70 °C.
For preparation of whole-cell extracts, tissues were 
homogenized with a glass–Teflon homogenizer in 5 
volumes (w/v) of ice-cold RIPA buffer (50 mM Tris-HCl, 
pH 7.2, 1 mM EDTA-Na2, 150 mM NaCl, 0.1% SDS, 1% 
Nonidet P-40, 0.5% sodium deoxycholate, 2 mM DTT, and 
protease and phosphatase inhibitors) and the homogenates 
were sonicated (3 × 30 s, 1 A, 50/60 Hz). After 60 min of 
incubation on ice with continuous agitation and frequent 
vortexing, the suspensions were centrifuged (16000 × g, 20 
min, 4 °C) and the resulting supernatants were divided into 
aliquots, stored at –70 °C, and used as whole-cell extracts. 
The protein content of all cellular fractions was 
determined using Spector’s (1978) method with bovine 
serum albumin as the standard.
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2.4. RNA isolation, reverse transcription, and real-time 
PCR
Total RNA was extracted from the liver of each animal 
using TRIreagent (AmBion Inc., Austin, TX, USA). 
Quantitative and qualitative evaluation of the isolated 
RNA was performed spectrophotometrically (OD 260/280 
> 1.8 was considered satisfactory) and on 2% agarose gel. 
Reverse transcription was performed using a high-capacity 
cDNA reverse transcription kit (Applied Biosystems) 
according to the manufacturer’s instructions. The cDNAs 
were stored at –70 °C for later use. 
Quantification of target gene expression in the liver 
was performed using TaqMan real-time polymerase 
chain reaction (PCR) following a previously published 
protocol (Djordjevic et al., 2012). The probe set used 
for the quantification was ACC (Rn00573474_m1), 
FAS (Rn 01463550_m1), and hypoxanthine-guanine 
phosphoribosyltransferase (HPRT1; Rn01527840_m1*) 
(Applied Biosystems Assay-On-Demand Gene Expression 
Products). HPRT1 was used as an internal control for 
quantitative normalization of cDNA. 
2.5. Western blot analysis
After being boiled in Laemmli’s sample buffer, 40 µg of liver 
protein was resolved on 7.5% or 10% SDS-polyacrylamide 
gels (samples to be compared were always run on the same 
gel). The transfer of proteins from the gels to polyvinylidene 
fluoride membranes (Immobilon-FL, Millipore) was 
done overnight at 135 mA and 4 °C in a transfer buffer 
(25 mM Tris-HCl, pH 8.3, 192 mM glycine, and 20% 
methanol). Membranes were incubated overnight at 4 °C 
with the following rabbit polyclonal antibodies (all from 
Santa Cruz Biotechnology): anti-PPARα (sc-9000, 1:250), 
anti-PGC-1α (sc-13067, 1:250), anti-lipin-1 (sc-98450, 
1:500), anti-CPT1 (sc-139482, 1:500), and anti-SREBP-1c 
(sc-366, 1:500). Mouse monoclonal anti-β-actin antibody 
(AC-15, Sigma-Aldrich, 1:10000) was used for equal 
load control. The membranes were incubated for 90 
min with alkaline phosphatase conjugated secondary 
antibodies (Amersham Pharmacia Biotech, 1:20,000). 
Immunopositive bands were visualized using an enhanced 
chemifluorescent method on the STORM 840 Gel and Blot 
Imaging System (GE Healthcare) and quantified using 
ImageQuant (GE Healthcare).
2.6. Statistical analyses 
The data for energy intake as well as morphological and 
biochemical parameters are given as mean ± SD (n = 9). 
Real-time PCR and western blot data are presented as 
mean ± SEM (n = 9). The normality of data distribution 
was tested using the Shapiro–Wilk test. Between-group 
comparisons were performed using the Student unpaired 
t-test. Statistical analyses were performed using GraphPad 
Prism v.5. Results were considered statistically significant 
at P < 0.05.
3. Results
3.1. Effect of dietary fructose on energy intake; body, liver, 
and adipose tissue masses; and biochemical parameters
Food intake was significantly lower (Table, P < 0.05) 
while energy intake was higher for the fructose-fed rats as 
compared to the controls (Table, P < 0.01). No significant 
between-group differences in body and liver masses were 
observed, but liver-to-body ratio was augmented in the 
fructose-fed rats. Moreover, rats consuming the fructose 
solution showed increased absolute (Table, P < 0.05) and 
relative (P < 0.05) visceral adipose tissue masses compared 
to the controls. Long-term consumption of the 60% fructose 
Table. The effects of a fructose-enriched diet on body, liver, and visceral adipose tissue (VAT) 
masses, energy intake, and biochemical parameters. *P < 0.05, **P < 0.01.
Diet Control Fructose P
Daily food intake (g/animal) 21.73 ± 0.73 16.99 ± 2.71* 0.034
Daily caloric intake (kJ/animal) 239.05 ± 8.05 324.4 ± 23.8** 0.003
Body mass (g) 333.50 ± 32.34 345.64 ± 32.95 0.435
Liver mass (g) 11.37 ± 1.57 12.80 ± 1.40 0.064
Liver-to-body ratio (×1000) 34.00 ± 1.98 37.05 ± 3.21* 0.021
VAT mass (g) 4.37 ± 1.73 6.26 ± 1.62* 0.039
VAT-to-body ratio (×1000) 13.26 ± 5.10 18.21 ± 4.64* 0.049
Glucose (mmol/L) 4.08 ± 0.30 3.88 ± 0.24 0.157
Triglycerides (mmol/L) 1.13 ± 0.25 1.55 ± 0.32** 0.006
FFAs (mmol/L) 0.69 ± 0.18 0.70 ± 0.32 0.901
Triglycerides in the liver (mmol/L) 1.37 ± 0.70 1.20 ± 0.31 0.392
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solution led to a significant increase in triglyceride levels 
in the blood (Table, P < 0.01), while plasma glucose and 
FFA levels remained unchanged after the high-fructose 
diet (Table). In addition, the liver triglycerides were not 
different between the two groups (Table).
3.2. Lipid metabolism in the livers of fructose-fed rats
To evaluate the effects of the fructose solution on the key 
regulators of lipid metabolism in the liver, we analyzed the 
concentration and cytoplasmic/nuclear redistribution of 
proteins involved in the regulation of mitochondrial fatty 
acid β-oxidation and de novo lipogenesis. We observed 
that 60% fructose consumption led to a significant 
decrease of PPARα in the cytoplasmic fraction (Figure 
1a, P < 0.001) and a concomitant elevation in the nuclear 
fraction (Figure 1b, P < 0.01). The analysis of PGC-1α 
intracellular redistribution showed that its cytoplasmic 
level was decreased (Figure 2a, P < 0.05), while its nuclear 
level remained unchanged (Figure 2b). Concomitantly, 
the levels of another transcription cofactor involved in 
β-oxidation, lipin-1, were unaltered in the cytoplasmic 
and nuclear fractions of the livers of fructose-fed animals 
(Figures 3a and 3b). Since nuclear accumulation of 
PGC-1α and lipin-1 can enforce the transcription of the 
CPT1 gene, the observation that a fructose diet did not 
affect the nuclear levels of these proteins is in accordance 
with the finding of decreased CPT1 protein levels in the 
livers of fructose-fed animals (Figure 4, P < 0.05).
When we examined the key hepatic lipogenic 
transcription factor SREBP-1c, we noticed a significant 
increase in its nuclear concentration (Figure 5a, P < 
0.05). Furthermore, the mRNA level of SREBP-1c target 
genes ACC and FAS were also increased in the livers of 
fructose-fed rats (Figures 5b and 5c, P < 0.05).
4. Discussion
In the present study, we examined the effects of high dietary 
fructose (60% solution) on the development of metabolic 
syndrome features and on hepatic lipid metabolism in a 
rodent model. The results demonstrated that rats exposed 
to a fructose-enriched diet were hypertriglyceridemic and 
normoglycemic, with no significant differences in body 
and liver masses in comparison to the controls; however, 
these animals showed signs of increased visceral adiposity 
and augmented liver-to-body ratio. These metabolic 
alterations most likely resulted from the simultaneous 
induction of hepatic lipogenic factors SREBP-1c, ACC, 
and FAS, and the inhibition of mitochondrial β-oxidation. 
In spite of the decreased fatty acid oxidation nuclear 
PPARα was increased, implying that it has a role in 
hepatic lipogenesis. The alleviation of fructose-induced 
metabolic disturbances could be achieved by the use of 
pharmacological stimulators of fatty acid oxidation.
In our study, caloric intake was higher for the fructose-
fed rats, but both body weight and liver mass were 
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Figure 1. Subcellular distribution of PPARα protein in the liver after a fructose-rich diet. Representative western blots and relative 
quantification of the PPARα protein are shown in the hepatic cytoplasmic (a) and nuclear (b) fractions of the control (C) and 
fructose-fed (F) rats. The lower parts of the blots were probed with antibodies against β-actin, which was used as a loading 
control. Values are means ± SEM and are presented as folds of the control (n = 9). Comparisons between the groups were made 
using an unpaired Student t-test. Asterisks indicate significant differences, **P < 0.01 and ***P < 0.001.
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unaffected by the applied diet regime, which is consistent 
with the results obtained from another animal study using 
a 60% fructose diet (Kelley et al., 2004). The fructose-fed 
group had significantly increased adipose tissue mass and 
a higher visceral adipose tissue-to-body ratio, pointing 
to visceral adiposity. The liver-to-body ratio was also 
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Figure 2. Subcellular distribution of PGC-1 protein in the liver after a fructose-rich diet. Representative western blots and 
relative quantification of the PGC-1 protein are shown in the hepatic cytoplasmic (a) and nuclear (b) fractions of the control (C) 
and fructose-fed (F) rats. The lower parts of the blots were probed with antibodies against β-actin, which was used as a loading 
control. Values are means ± SEM and are presented as folds of the control (n = 9). Comparisons between the groups were made 
using an unpaired Student t-test. Asterisks indicate a significant difference, *P < 0.05.
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Figure 3. Subcellular distribution of lipin-1 protein in the liver after a fructose-rich diet. Representative western blots and relative 
quantification of the lipin-1 protein are shown in the hepatic cytoplasmic (a) and nuclear (b) fractions of the control (C) and 
fructose-fed (F) rats. The lower parts of the blots were probed with antibodies against β-actin, which was used as a loading 
control. Values are means ± SEM and are presented as folds of the control (n = 9). Comparisons between the groups were made 
using an unpaired Student t-test.
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increased in the fructose-fed animals; however, this was 
not accompanied by an accumulation of triglycerides in 
the liver. The hypertriglyceridemia observed in the 60% 
fructose-fed animals represents a metabolic hallmark of 
fructose-enriched diets (Roglans et al., 2007; Rebollo et 
al., 2014a). This was not associated with increased plasma 
FFA levels, which is in accordance with some other studies 
(Roglans et al., 2002; Menard et al., 2010). It is well known 
that hepatic production of very-low-density lipoproteins 
(VLDLs) is primarily responsible for hypertriglyceridemia 
(Wang et al., 1984) and that the main regulator of 
hepatic lipogenesis is SREBP-1c, which acts through 
transcriptional control of ACC and FAS. In this study, we 
detected an increased level of active SREBP-1c followed by 
enhanced ACC and FAS gene expression. Taken together, 
these results point toward increased de novo lipogenesis, 
presumably due to the accumulation of lipogenic 
precursors upon high fructose consumption. On the other 
hand, mitochondrial fatty acid β-oxidation was inhibited, 
as judged by the significantly decreased CPT1 level in 
the whole-cell extract. This is probably due to higher 
ACC expression that could lead to increased production 
of malonyl-CoA, which is an inhibitor of CPT1 and 
consequently of fatty acid oxidation (Rodriguez-Calvo et 
al., 2009). However, in spite of the reduced β-oxidation, we 
observed increased levels of nuclear PPARα protein, which 
can be explained by the fact that PPARα is also involved in 
the regulation of hepatic lipid metabolism apart being a 
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Figure 4. The effect of a fructose-rich diet on CPT1 protein level in 
the liver. Representative western blots and relative quantification 
of the CPT1 protein are shown in the whole-cell extract of the 
livers of the control (C) and fructose-fed (F) rats. The lower parts 
of the blots were probed with antibody against β-actin, which 
was used as a loading control. Values are means ± SEM and are 
presented as folds of the control (n = 9). Comparisons between 
the groups were made using an unpaired Student t-test. Asterisks 
indicate a significant difference, *P < 0.05.
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Figure 5. The effect of a fructose-rich diet on SREBP-1c protein level and gene expression of ACC and FAS in the liver. Representative 
western blots and relative quantification of the SREBP-1c protein are shown in the hepatic nuclear fractions of the control (C) and 
fructose-fed (F) rats. Lower parts of the blots were probed with antibody against β-actin, which was used as a loading control (a). 
Relative quantification of ACC (b) and FAS (c) mRNA levels in the livers were done relative to the amount of HPRT1 mRNA. Values are 
means ± SEM and are presented as folds of the control (n = 9). Comparisons between the groups were made using an unpaired Student 
t-test. Asterisks indicate a significant difference, *P < 0.05.
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regulator of fatty acid oxidation (Oosterveer et al., 2009). 
Namely, increased PPARα activity was shown to enhance 
the flux of fatty acids from the adipose tissue to the liver via 
stimulation of fibroblast growth factor 21 gene expression 
(Inagaki et al., 2007), thus maintaining circulating FFA 
concentrations at a constant level. Moreover, PPARα seems 
to be a transcriptional activator of SREBP-1c (Fernandez-
Alvarez et al., 2011) and SCD1 (Miller and Ntambi, 1996), 
two main promoters of de novo lipogenesis. Since in 
this study we observed an increased expression of active 
SREBP-1c and FAS in the livers of the fructose-fed rats 
as well as an unchanged level of plasma FFAs, we suggest 
that the hepatic PPARα activation in these animals was 
predominantly associated with stimulated lipogenesis 
(Chakravarthy et al., 2005). 
The expected outcome of enhanced de novo 
lipogenesis should be a high rate of triglyceride secretion 
in the form of VLDLs or the ectopic accumulation of 
lipids in the hepatocytes (Kawano and Cohen, 2013). 
In the present study, 60% fructose consumption was 
found to be associated with hypertriglyceridemia. On 
the other hand, we did not observe excessive triglyceride 
accumulation in the liver, which is in accordance with the 
results of other animal studies using a 60% fructose diet 
(Kelley et al., 2004; de Moura et al., 2009). According to 
these results, we presume that the hepatic overproduction 
of triglyceride-rich lipoproteins due to a liquid high-
fructose diet is channeled into secretory pathways instead 
of being accumulated in the liver, resulting in excessive 
visceral adiposity (Sam et al., 2009) and an increased risk 
of metabolic complications (Lemieux et al., 2007). The 
observed hypertriglyceridemia without concomitant signs 
of hepatic steatosis may merely reflect an adaptation to a 
high-fructose diet (Tappy and Le, 2015) that still has not 
progressed to pathological status. 
In summary, the results of the present study indicate 
that consumption of 60% fructose solution disturbs 
hepatic lipid metabolism by simultaneously inducing de 
novo lipogenesis and inhibiting fatty acid β-oxidation, thus 
resulting in hypertriglyceridemia and visceral adiposity, 
but without ectopic hepatic lipid deposition. Future 
longitudinal studies are required to elucidate the timing 
of hepatic mitochondrial dysfunction and lipogenesis 
in relation to fructose-induced metabolic syndrome 
development.
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